Mirati Therapeutics Inc (NASDAQ:MRTX)

118.52
Delayed Data
As of 4:00pm ET
 -2.29 / -1.90%
Today’s Change
115.57
Today|||52-Week Range
225.47
-19.20%
Year-to-Date
Should Investors Worry About Mirati Therapeutics Inc's Insider Sells?
2:54am / GuruFocus News - Paid Partner Content
Why Mirati Therapeutics Was Sinking This Week
Jan 14 / MotleyFool.com - Paid Partner Content
BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study
Jan 14 / Zacks.com - Paid Partner Content
Amgen's (AMGN) KRAS Inhibitor Gets Nod for Lung Cancer in EU
Jan 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close120.81
Today’s open122.97
Day’s range117.66 - 124.34
Volume17,301
Average volume (3 months)544,981
Market cap$6.9B
Data as of 4:00pm ET, 01/20/2022

Growth & Valuation

Earnings growth (last year)-39.79%
Earnings growth (this year)-32.61%
Earnings growth (next 5 years)-92.03%
Revenue growth (last year)+301.74%
P/E ratioNM
Price/Sales737.50
Price/Book4.60

Competitors

----
----
----
EVOEvotec SE+0.35+1.70%
Data as of 4:00pm ET, 01/20/2022

Financials

Next reporting dateMarch 10, 2022
EPS forecast (this quarter)-$2.97
Annual revenue (last year)$13.4M
Annual profit (last year)-$357.9M
Net profit margin-2,671.57%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts